3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
5
Other hematologic neoplasm
5
Myeloid
5
Lymphoid
4
Gastrointestinal
4
Thoracic
3
Other neoplasm
3
CNS
3
NET
2
Genitourinary
2
Endocrine
2
Plasma cell
1
Head & Neck
1
Gynecologic
1
Dermatologic
1
Breast
1
Conditions
Multiple Myeloma
420
Lymphoma
53
Recurrence
42
Neoplasms, Plasma Cell
33
Hematologic Neoplasms
33
Immunoglobulin Light-chain Amyloidosis
29
Smoldering Multiple Myeloma
26
Lymphoma, Non-Hodgkin
25
Leukemia, Myeloid, Acute
20
Leukemia, Lymphocytic, Chronic, B-Cell
20
Neoplasms
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Hodgkin Disease
17
Myelodysplastic Syndromes
16
Monoclonal Gammopathy of Undetermined Significance
13
Waldenstrom Macroglobulinemia
11
Lymphoma, Mantle-Cell
11
Leukemia
11
Prostatic Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Breast Neoplasms
10
Paraproteinemias
9
Ovarian Neoplasms
9
Lung Neoplasms
8
Leukemia, Plasma Cell
8
Amyloidosis
8
Melanoma
7
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms by Histologic Type
×
Plasma cell
×
90 days
×
Clear all
NCT07075185
2026-04-24
inMMyCAR
Kelonia Therapeutics, Inc.
Phase 1
Recruiting
70 enrolled